JOHN TEIXEIRA, Associate Director of Commercial Operations

Safety and efficacy are a critical part of pharmaceutical manufacturing, and the risks inherent to those processes can feel even more consequential when it comes to treatments for our eyes. Ophthalmic treatments, which include solutions, drops, or ointments used to treat conditions of the eye, require a manufacturing partner with the expertise, impeccable quality assurance practices, and modern equipment necessary to ensure a safe, effective drug product.

Read the full white paper by completing the form below.